Vaccine adjuvants: key tools for innovative vaccine design.
Curr Top Med Chem. 2013.
PMID: 24066891
Review.
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2013 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Search Results
5 results
Results by year
Citations
1
article
found by citation matching
Search results
Page 1
Vaccine adjuvants: key tools for innovative vaccine design.
Curr Top Med Chem. 2013;13(20):2562-80. doi: 10.2174/15680266113136660183.
Curr Top Med Chem. 2013.
PMID: 24066891
Review.
Newly arising immunization approaches, such as subunit vaccines and mucosal administration, make the use of novel adjuvants essential. However, only a limited number of adjuvants are available on the market. The present review is focused on vaccine …
Newly arising immunization approaches, such as subunit vaccines and mucosal administration, make the use of novel adjuvants es …
Novel Vaccine Adjuvants as Key Tools for Improving Pandemic Preparedness.
Bioengineering (Basel). 2021 Oct 24;8(11):155. doi: 10.3390/bioengineering8110155.
Bioengineering (Basel). 2021.
PMID: 34821721
Free PMC article.
During the current COVID-19 pandemic, recent advances in mRNA engineering have proven paramount in the rapid design and production of effective vaccines. Comparatively, however, the development of new adjuvants capable of enhancing vaccine efficacy has …
During the current COVID-19 pandemic, recent advances in mRNA engineering have proven paramount in the rapid design and production of …
Transforming vaccinology.
Cell. 2024 Sep 19;187(19):5171-5194. doi: 10.1016/j.cell.2024.07.021.
Cell. 2024.
PMID: 39303685
Review.
Here, we provide a historic perspective on the key innovations that led to the development of some 27 licensed vaccines over the past two centuries and recent advances that promise to transform vaccines in the future. ...Likewise, the speed and flexibi …
Here, we provide a historic perspective on the key innovations that led to the development of some 27 licensed vaccines …
Peptide-Based Vaccines for Tuberculosis.
Front Immunol. 2022 Jan 31;13:830497. doi: 10.3389/fimmu.2022.830497. eCollection 2022.
Front Immunol. 2022.
PMID: 35173740
Free PMC article.
Review.
Furthermore, innovations in bioinformatics, immunoinformatics, synthetic technologies, new materials, and transgenic animal models have put wings on the research of peptide-based vaccines for TB. Hence, this review seeks to give an overview of current tools t …
Furthermore, innovations in bioinformatics, immunoinformatics, synthetic technologies, new materials, and transgenic animal models ha …
In silico design of a broad-spectrum multiepitope vaccine against influenza virus.
Int J Biol Macromol. 2024 Jan;254(Pt 3):128071. doi: 10.1016/j.ijbiomac.2023.128071. Epub 2023 Nov 14.
Int J Biol Macromol. 2024.
PMID: 37967595
Influenza remains a global health concern due to its potential to cause pandemics as a result of rapidly mutating influenza virus strains. Existing vaccines often struggle to keep up with these rapidly mutating flu viruses. Therefore, the development of a broad-spectrum pe …
Influenza remains a global health concern due to its potential to cause pandemics as a result of rapidly mutating influenza virus strains. E …
Cite